Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

Publication date: Jan 19, 2024

The primary purpose of this study is to learn about how well different versions of the Pfizer-BioNTech COVID-19 vaccine (called BNT162b2) work at preventing death, severe COVID-19 that requires a trip to the hospital, and overall use of healthcare resources, such as needing to go the doctor or urgent care due to illness. Pfizer is not enrolling any participants for this study. Instead, existing data from different health data sources will be used to help answer the scientific questions Pfizer is interested in learning more about.

Concepts Keywords
Bnt162b2 Bnt162b2
California California
Death Claims
Louisiana Covid
Vaccine Criteria
Effectiveness
Formulations
Healthverity
Insurance
Louisiana
Pfizer
Registry
Study
Vaccine
Year

Semantics

Type Source Name
disease VO effectiveness
disease VO vaccine
disease VO COVID-19 vaccine
disease MESH death
disease MESH COVID-19
disease VO immunization

Original Article

(Visited 1 times, 1 visits today)